Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Kidney Int. 2014 Sep 17;87(3):640–648. doi: 10.1038/ki.2014.301

Figure 4. Area Under the Receiver Operating Curves (AUC-ROCs) combining the clinical model with the addition of each biomarker to measure discrimination between patients with KDIGO Stage 1 injury who experience and do not experience a persistent doubling of baseline creatinine, dialysis, or death within 7 days of biomarker measurement.

Figure 4

(a) clinical model alone (thin black solid line), (b) clinical model + uNGAL (black dotted line), (c) clinical model + uL-FABP (thick black solid line), (d) clinical model + uIL-18 (black dashed line), and (e) clinical model + uKIM-1 (gray solid line). 95% Confidence Intervals also shown.